- IBDEI14F ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,18185,0)
- ;;=E11.620^^61^805^5
- ;;^UTILITY(U,$J,358.3,18185,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,18185,1,3,0)
- ;;=3^DM Type 2 w/ Diab Dermatitis
- ;;^UTILITY(U,$J,358.3,18185,1,4,0)
- ;;=4^E11.620
- ;;^UTILITY(U,$J,358.3,18185,2)
- ;;=^5002655
- ;;^UTILITY(U,$J,358.3,18186,0)
- ;;=E11.36^^61^805^4
- ;;^UTILITY(U,$J,358.3,18186,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,18186,1,3,0)
- ;;=3^DM Type 2 w/ Diab Cataract
- ;;^UTILITY(U,$J,358.3,18186,1,4,0)
- ;;=4^E11.36
- ;;^UTILITY(U,$J,358.3,18186,2)
- ;;=^5002642
- ;;^UTILITY(U,$J,358.3,18187,0)
- ;;=I10.^^61^806^1
- ;;^UTILITY(U,$J,358.3,18187,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,18187,1,3,0)
- ;;=3^Essential/Primary Hypertension
- ;;^UTILITY(U,$J,358.3,18187,1,4,0)
- ;;=4^I10.
- ;;^UTILITY(U,$J,358.3,18187,2)
- ;;=^5007062
- ;;^UTILITY(U,$J,358.3,18188,0)
- ;;=I11.0^^61^806^12
- ;;^UTILITY(U,$J,358.3,18188,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,18188,1,3,0)
- ;;=3^Hypertensive Heart Disease w/ Heart Failure
- ;;^UTILITY(U,$J,358.3,18188,1,4,0)
- ;;=4^I11.0
- ;;^UTILITY(U,$J,358.3,18188,2)
- ;;=^5007063
- ;;^UTILITY(U,$J,358.3,18189,0)
- ;;=I11.9^^61^806^13
- ;;^UTILITY(U,$J,358.3,18189,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,18189,1,3,0)
- ;;=3^Hypertensive Heart Disease w/o Heart Failure
- ;;^UTILITY(U,$J,358.3,18189,1,4,0)
- ;;=4^I11.9
- ;;^UTILITY(U,$J,358.3,18189,2)
- ;;=^5007064
- ;;^UTILITY(U,$J,358.3,18190,0)
- ;;=I12.0^^61^806^5
- ;;^UTILITY(U,$J,358.3,18190,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,18190,1,3,0)
- ;;=3^Hypertensive CKD w/ Stage 5 CKD or ESRD
- ;;^UTILITY(U,$J,358.3,18190,1,4,0)
- ;;=4^I12.0
- ;;^UTILITY(U,$J,358.3,18190,2)
- ;;=^5007065
- ;;^UTILITY(U,$J,358.3,18191,0)
- ;;=I12.9^^61^806^4
- ;;^UTILITY(U,$J,358.3,18191,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,18191,1,3,0)
- ;;=3^Hypertensive CKD w/ Stage 1-4 CKD
- ;;^UTILITY(U,$J,358.3,18191,1,4,0)
- ;;=4^I12.9
- ;;^UTILITY(U,$J,358.3,18191,2)
- ;;=^5007066
- ;;^UTILITY(U,$J,358.3,18192,0)
- ;;=I13.0^^61^806^8
- ;;^UTILITY(U,$J,358.3,18192,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,18192,1,3,0)
- ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 1-4 CKD
- ;;^UTILITY(U,$J,358.3,18192,1,4,0)
- ;;=4^I13.0
- ;;^UTILITY(U,$J,358.3,18192,2)
- ;;=^5007067
- ;;^UTILITY(U,$J,358.3,18193,0)
- ;;=I13.10^^61^806^10
- ;;^UTILITY(U,$J,358.3,18193,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,18193,1,3,0)
- ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 1-4 CKD
- ;;^UTILITY(U,$J,358.3,18193,1,4,0)
- ;;=4^I13.10
- ;;^UTILITY(U,$J,358.3,18193,2)
- ;;=^5007068
- ;;^UTILITY(U,$J,358.3,18194,0)
- ;;=I13.11^^61^806^11
- ;;^UTILITY(U,$J,358.3,18194,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,18194,1,3,0)
- ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
- ;;^UTILITY(U,$J,358.3,18194,1,4,0)
- ;;=4^I13.11
- ;;^UTILITY(U,$J,358.3,18194,2)
- ;;=^5007069
- ;;^UTILITY(U,$J,358.3,18195,0)
- ;;=I13.2^^61^806^9
- ;;^UTILITY(U,$J,358.3,18195,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,18195,1,3,0)
- ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
- ;;^UTILITY(U,$J,358.3,18195,1,4,0)
- ;;=4^I13.2
- ;;^UTILITY(U,$J,358.3,18195,2)
- ;;=^5007070
- ;;^UTILITY(U,$J,358.3,18196,0)
- ;;=I15.0^^61^806^15
- ;;^UTILITY(U,$J,358.3,18196,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,18196,1,3,0)
- ;;=3^Renovascular Hypertension
- ;;^UTILITY(U,$J,358.3,18196,1,4,0)
- ;;=4^I15.0
- ;;^UTILITY(U,$J,358.3,18196,2)
- ;;=^5007071
- ;;^UTILITY(U,$J,358.3,18197,0)
- ;;=I15.1^^61^806^3
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI14F 3791 printed Feb 18, 2025@23:27:54 Page 2
- IBDEI14F ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,18185,0)
- +2 ;;=E11.620^^61^805^5
- +3 ;;^UTILITY(U,$J,358.3,18185,1,0)
- +4 ;;=^358.31IA^4^2
- +5 ;;^UTILITY(U,$J,358.3,18185,1,3,0)
- +6 ;;=3^DM Type 2 w/ Diab Dermatitis
- +7 ;;^UTILITY(U,$J,358.3,18185,1,4,0)
- +8 ;;=4^E11.620
- +9 ;;^UTILITY(U,$J,358.3,18185,2)
- +10 ;;=^5002655
- +11 ;;^UTILITY(U,$J,358.3,18186,0)
- +12 ;;=E11.36^^61^805^4
- +13 ;;^UTILITY(U,$J,358.3,18186,1,0)
- +14 ;;=^358.31IA^4^2
- +15 ;;^UTILITY(U,$J,358.3,18186,1,3,0)
- +16 ;;=3^DM Type 2 w/ Diab Cataract
- +17 ;;^UTILITY(U,$J,358.3,18186,1,4,0)
- +18 ;;=4^E11.36
- +19 ;;^UTILITY(U,$J,358.3,18186,2)
- +20 ;;=^5002642
- +21 ;;^UTILITY(U,$J,358.3,18187,0)
- +22 ;;=I10.^^61^806^1
- +23 ;;^UTILITY(U,$J,358.3,18187,1,0)
- +24 ;;=^358.31IA^4^2
- +25 ;;^UTILITY(U,$J,358.3,18187,1,3,0)
- +26 ;;=3^Essential/Primary Hypertension
- +27 ;;^UTILITY(U,$J,358.3,18187,1,4,0)
- +28 ;;=4^I10.
- +29 ;;^UTILITY(U,$J,358.3,18187,2)
- +30 ;;=^5007062
- +31 ;;^UTILITY(U,$J,358.3,18188,0)
- +32 ;;=I11.0^^61^806^12
- +33 ;;^UTILITY(U,$J,358.3,18188,1,0)
- +34 ;;=^358.31IA^4^2
- +35 ;;^UTILITY(U,$J,358.3,18188,1,3,0)
- +36 ;;=3^Hypertensive Heart Disease w/ Heart Failure
- +37 ;;^UTILITY(U,$J,358.3,18188,1,4,0)
- +38 ;;=4^I11.0
- +39 ;;^UTILITY(U,$J,358.3,18188,2)
- +40 ;;=^5007063
- +41 ;;^UTILITY(U,$J,358.3,18189,0)
- +42 ;;=I11.9^^61^806^13
- +43 ;;^UTILITY(U,$J,358.3,18189,1,0)
- +44 ;;=^358.31IA^4^2
- +45 ;;^UTILITY(U,$J,358.3,18189,1,3,0)
- +46 ;;=3^Hypertensive Heart Disease w/o Heart Failure
- +47 ;;^UTILITY(U,$J,358.3,18189,1,4,0)
- +48 ;;=4^I11.9
- +49 ;;^UTILITY(U,$J,358.3,18189,2)
- +50 ;;=^5007064
- +51 ;;^UTILITY(U,$J,358.3,18190,0)
- +52 ;;=I12.0^^61^806^5
- +53 ;;^UTILITY(U,$J,358.3,18190,1,0)
- +54 ;;=^358.31IA^4^2
- +55 ;;^UTILITY(U,$J,358.3,18190,1,3,0)
- +56 ;;=3^Hypertensive CKD w/ Stage 5 CKD or ESRD
- +57 ;;^UTILITY(U,$J,358.3,18190,1,4,0)
- +58 ;;=4^I12.0
- +59 ;;^UTILITY(U,$J,358.3,18190,2)
- +60 ;;=^5007065
- +61 ;;^UTILITY(U,$J,358.3,18191,0)
- +62 ;;=I12.9^^61^806^4
- +63 ;;^UTILITY(U,$J,358.3,18191,1,0)
- +64 ;;=^358.31IA^4^2
- +65 ;;^UTILITY(U,$J,358.3,18191,1,3,0)
- +66 ;;=3^Hypertensive CKD w/ Stage 1-4 CKD
- +67 ;;^UTILITY(U,$J,358.3,18191,1,4,0)
- +68 ;;=4^I12.9
- +69 ;;^UTILITY(U,$J,358.3,18191,2)
- +70 ;;=^5007066
- +71 ;;^UTILITY(U,$J,358.3,18192,0)
- +72 ;;=I13.0^^61^806^8
- +73 ;;^UTILITY(U,$J,358.3,18192,1,0)
- +74 ;;=^358.31IA^4^2
- +75 ;;^UTILITY(U,$J,358.3,18192,1,3,0)
- +76 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 1-4 CKD
- +77 ;;^UTILITY(U,$J,358.3,18192,1,4,0)
- +78 ;;=4^I13.0
- +79 ;;^UTILITY(U,$J,358.3,18192,2)
- +80 ;;=^5007067
- +81 ;;^UTILITY(U,$J,358.3,18193,0)
- +82 ;;=I13.10^^61^806^10
- +83 ;;^UTILITY(U,$J,358.3,18193,1,0)
- +84 ;;=^358.31IA^4^2
- +85 ;;^UTILITY(U,$J,358.3,18193,1,3,0)
- +86 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 1-4 CKD
- +87 ;;^UTILITY(U,$J,358.3,18193,1,4,0)
- +88 ;;=4^I13.10
- +89 ;;^UTILITY(U,$J,358.3,18193,2)
- +90 ;;=^5007068
- +91 ;;^UTILITY(U,$J,358.3,18194,0)
- +92 ;;=I13.11^^61^806^11
- +93 ;;^UTILITY(U,$J,358.3,18194,1,0)
- +94 ;;=^358.31IA^4^2
- +95 ;;^UTILITY(U,$J,358.3,18194,1,3,0)
- +96 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
- +97 ;;^UTILITY(U,$J,358.3,18194,1,4,0)
- +98 ;;=4^I13.11
- +99 ;;^UTILITY(U,$J,358.3,18194,2)
- +100 ;;=^5007069
- +101 ;;^UTILITY(U,$J,358.3,18195,0)
- +102 ;;=I13.2^^61^806^9
- +103 ;;^UTILITY(U,$J,358.3,18195,1,0)
- +104 ;;=^358.31IA^4^2
- +105 ;;^UTILITY(U,$J,358.3,18195,1,3,0)
- +106 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
- +107 ;;^UTILITY(U,$J,358.3,18195,1,4,0)
- +108 ;;=4^I13.2
- +109 ;;^UTILITY(U,$J,358.3,18195,2)
- +110 ;;=^5007070
- +111 ;;^UTILITY(U,$J,358.3,18196,0)
- +112 ;;=I15.0^^61^806^15
- +113 ;;^UTILITY(U,$J,358.3,18196,1,0)
- +114 ;;=^358.31IA^4^2
- +115 ;;^UTILITY(U,$J,358.3,18196,1,3,0)
- +116 ;;=3^Renovascular Hypertension
- +117 ;;^UTILITY(U,$J,358.3,18196,1,4,0)
- +118 ;;=4^I15.0
- +119 ;;^UTILITY(U,$J,358.3,18196,2)
- +120 ;;=^5007071
- +121 ;;^UTILITY(U,$J,358.3,18197,0)
- +122 ;;=I15.1^^61^806^3